← All stocks

Vaxcyte, Inc.

PCVX Net selling
CIK 0001649094 #979 in the set updated 17 Sep 2026
Bought (120 mo)
$20.69M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$139.01M
$11.76M on a plan · $72.03M straight out of an exercise
Sold at will
$55.22M
92 of 552 sales
Net
−$118.32M
−$34.53M against sales at will

By person

26 insiders · 582 transactions
51.8×

Grant E. Pickering holds 51.8 times base salary in stock. $41.45M of shares against $800.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Grant E. Pickering last reported holding, valued at $59.52, the price Common Stock was last bought or sold at on the open market here, on 9 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
PICKERING GRANT
CHIEF EXECUTIVE OFFICER
$39.81M (194) scheduled
−$39.81M
696,332
0.4679%
$41.45M
+8.5%
RA CAPITAL MANAGEMENT, L.P. entity
10% owner
$24.77M (5)
−$24.77M
5,001,593
3.36%
$297.70M
−8.6%
Hopfner Robert Lorne
Director
$1.49M (1)
$22.04M (40)
−$20.55M
1,405,418
0.9445%
$83.65M
GUGGENHIME ANDREW
PRESIDENT AND CFO
$18.70M (68) scheduled
−$18.70M
219,016
0.1472%
$13.04M
+214.1%
TPG Group Holdings (SBS) Advisors, Inc. entity
Former 10% Owner
$15.00M (1)
$2.66M (2)
+$12.34M
5,074,574
3.41%
$302.04M
Wassil Jim
EVP, Chief Scientific Ofc, COO
$11.19M (92) scheduled
−$11.19M
145,435
0.0977%
$8.66M
+1,012%
Eydelman Mikhail
SVP, GEN COUNSEL & CORP SEC
$6.10M (59) scheduled
−$6.10M
41,620
0.0280%
$2.48M
+1,658%
Heron Patrick J
Director
$4.00M (1)
+$4.00M
2,309,554
1.55%
$137.47M
Cowan Elvia
SVP, Finance & CAO
$3.22M (12) scheduled
−$3.22M
27,860
0.0187%
$1.66M
+904.7%
Fairman Jeff
VP, Research
$2.91M (30)
−$2.91M
303,370
0.2039%
$18.06M
−12.0%
Lukatch Heath
Director
$1.94M (14) scheduled
−$1.94M
19,481
0.0131%
$1.16M
Dhaliwal Harpreet S.
Chief Technical Ops Officer
$1.39M (2) scheduled
−$1.39M
68,085
0.0458%
$4.05M
+295.5%
Gilbert Halley E
Director
$1.33M (1) scheduled
−$1.33M
12,481
0.0084%
$742.88K
Loxam Teri
Director
$1.26M (12) scheduled
−$1.26M
12,481
0.0084%
$742.88K
Sauer Paul
SVP Process Dev, Manufacturing
$1.16M (15)
−$1.16M
13,822
0.0093%
$822.70K
−83.0%
Wright-Mitchell Jane
General Counsel
$525.61K (6) scheduled
−$525.61K
3,125
0.0021%
$186.00K
0.0%
EMSTER KURT VON
Director
$200.00K (1)
+$200.00K
4,168,718
2.80%
$248.13M
NEWELL WILLIAM J
Director
66,684
0.0448%
$3.97M
+50.0%
Jodar Luis
Chief Medical Officer
52,632
0.0354%
$3.13M
Paya Carlos V
Director
12,481
0.0084%
$742.88K
Drapeau Anne S
Director
12,481
0.0084%
$742.88K
Hirth Peter
Director
7,175
0.0048%
$427.06K
Lee Jacks
Director
6,856
0.0046%
$408.08K
Kamarck Michael E.
Director
5,625
0.0038%
$334.81K
Furey John
Director
5,306
0.0036%
$315.82K
BRANDICOURT OLIVIER
Director
4,699
0.0032%
$279.69K

Nothing of that kind in this period.

What was left out

Form 4 filings counted 380
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 116
Sales straight out of an exercise 344
Sales at will 92
Transactions with no price 0
Shares from compensation/vesting 15,668,882
Sales filed before the plan box existed 87
History held since 15 Jun 2020